Meet the team

Andrew Beggs is a Professor of Cancer Genetics & Surgery in the Institute of Cancer and Genomic Sciences, University of Birmingham. He is also the Deputy Director of the Birmingham Experimental Cancer Medicine Centre and Theme Lead for Biomarkers and Liquid Biopsy.  He also is Head of Somatic Cancer in the Central and South Genomic Medicine Service Alliance. He is Co-Lead of the Tran ...

Roy Bicknell originally read chemistry at St. John's College, University of Oxford before studying for a doctorate in The William Dunn School of Pathology, University of Oxford as an E.P.Abraham scholar. He then won a NATO Postdoctoral Fellowship to study at Harvard Medical School. His original research interest was bacterial resistance to antibiotics but at Harvard moved to growth and angiogenic ...

Rik Bryan is a former clinical urologist, and now a full-time bladder cancer research academic. He is the Chief Investigator of the Bladder Cancer Prognosis Programme (BCPP), the SELENIB clinical trial, and POUT-T. He is the Director of the Bladder Cancer Research Centre (BCRC) in the Institute of Cancer & Genomic Sciences. The BCRC has a particular interest in the proteomics, genomics and ...

Chris Buckley is the Kennedy Professor of Translational Rheumatology at the Universities of Birmingham and Oxford. He is  Director of Clinical Research at the Kennedy Institute of Rheumatology in Oxford. He leads the Arthritis Therapy Acceleration Programme (A-TAP) which aims to deliver “stratified pathology” in a range of immune mediated inflammatory diseases in order to choose ...

Jorge Caamaño is Reader in Cellular Immunology. He heads the Stroma-Immune Cell Interaction Group.

Jorge’s research focuses on secondary and tertiary lymphoid tissue development and function during immune responses and inflammation.

He has published over seventy articles in peer-reviewed scientific journals in the field of immunology, cell and developmental biology and signal ...

Charles Craddock is Academic Director of the Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, UK, and Professor of Haemato-oncology, at the University of Birmingham. He trained in haematology at the Hammersmith Hospital, London, the Institute of Molecular Medicine at the University of Oxford and the University of Washington, Seattle, USA.

Professor Craddock is a recent ...

Stuart is a liver immunologist who is closely involved in the development in novel vaccination approaches to treat hepatocellular carcinoma. In particular, his interests are in the field of immunotherapy with a focus on the use of immune cells to treat cancer. It is apparent that cancer patients with stronger anti-tumour immunity have the best prognosis. With new drugs becoming available to ...

Dr Carmela De Santo is an expert on tumour immunosuppression, and in particular on myeloid derived suppressor cells.

 

Sarah Dimeloe is a Birmingham Fellow working across the Institutes of Immunology and Immunotherapy (III), and Metabolism and Systems Research (IMSR).

Research in Sarah’s lab is focused on the metabolism of immune cells and how this underpins their role in health and disease.

Dr Dimeloe is a member of the 2017/18 Birmingham Fellows.

 

Mark has directed the CIS since 2000. The service provides a unique interface between the University's substantial scientific expertise in immunology and the clinical investigation and management of blood cancers, immunodeficiency and autoimmunity in the West Midlands. Providing 500,000 immunodiagnostic tests per year for a population of five million, the CIS is in an ideal position for ...

Sylvie Freeman is co-director of the Clinical Immunology Service, leading Immunophenotyping for the diagnosis and monitoring of haematological malignancies. The service provides a unique interface between the University's substantial scientific expertise in immunohaematology and the clinical investigation and management of blood cancers and immunodeficiency in the NHS and for trials.

Research ...

Mike Hawkins is Professor of Epidemiology and Director of the Centre for Childhood Cancer Survivors Studies.

He has published over 150 papers in peer-reviewed scientific and clinical journals mostly relating to the long-term health and social consequences of being treated for cancer. Mike has received programme grant funding from Cancer Research UK, the Kay Kendall Leukaemia Fund and the ...

Professor Peter Lane is interested in the molecular and cellular basis of CD4 memory and effector function, particularly in the context of human susceptibility to autoimmune disease. Acute and chronic autoimmune diseases are a huge burden to the NHS. Checkpoint inhibitors that suppress normal mechanisms that maintain self-tolerance, have been effective in revealing CD8 driven immune responses ...

Dr Heather Long is a Lecturer in Immunology in the Institute of Immunology and Immunotherapy, University of Birmingham.

Heather has published a number of research papers on the immune response to Epstein-Barr virus (EBV). Her long-term interest is in developing immune-based therapies for the treatment of EBV-associated and non virus-associated lymphomas. In particular, her group is focussed on ...

Kendle is a Birmingham Fellow working across the Institutes of Immunology and Immunotherapy (III), and Metabolism and Systems Research (IMSR).

Research in Kendle’s lab is focussed on understanding innate immune pathways in intestinal epithelial cells and their roles in fighting infection and cancer development.

Professor Hisham Mehanna is the chair of head and neck surgery, and is the Director of the Institute of Head and Neck Studies and Education (InHANSE) at the Institute of Cancer and Genomic Sciences.

Hisham is a head and neck and thyroid surgeon with clinical interests in recurrence in thyroid and parathyroid surgery. He has a keen interest in clinical and translational research, ...

Gary Middleton is Professor of Medical Oncology in the Institute of Immunology and Immunotherapy, Honorary Consultant Oncologist at University Hospitals Birmingham and Director of the Birmingham Experimental Cancer Medicine Centre (ECMC). He drives the translation of Birmingham cancer immunology and genomics science into novel clinical research, collaboratively delivered across the ECMC ...

Fiyaz is a Lecturer in Biomedical Structural Biology in the Institute of Immunology and Immunotherapy, University of Birmingham. His research focuses on investigating immune cell surface receptor/ligand interactions relevant to cancer using X-ray crystallography.

He has published a number of peer reviewed research papers on clinically relevant immune receptor recognition events including those ...

After Dion received his degree in Medicine from Bristol University in 1985, he took up an honorary consultant appointment at the University Hospitals Birmingham NHS Foundation Trust in 1996 and was appointed Professor of Surgery in 2006. In 2015, he became Barling Chair of Surgery. He is also Surgery Section Head at the Institute of Cancer and Genomics.

Dion was appointed Officer of the Order of ...

Paul Moss is Professor of Haematology within the Institute of Immunology and Immunotherapy at the University of Birmingham and Deputy Head of the College of Medical and Dental Sciences. He is an international figure in translational human immunology and an NIHR Senior Investigator. He was previously Chair of the Infection and Immunity Board at the Medical Research Council and also ...

Ye is a Professor of Autoimmune liver diseases and Translational Hepatology at the Institute of Immunology and Immunotherapy, University of Birmingham and Consultant Hepatologist at the Queen Elizabeth Hospital where he specialises in the management of autoimmune liver diseases, immune mediated liver injury and liver transplantation.

He currently holds Sir Jules Thorn Research Programme Award. ...

• ResearchGate

Dr Claire Shannon-Lowe is a tumour virologist with over 20 years of experience in virology research. At the University of Birmingham, her research has focussed upon Epstein Barr virus, the first human virus shown to be associated with cancer. She has a long-term interest in a group of rare T cell and natural killer cell cancers driven by EBV. These diseases are aggressive and ...

Dr Steven specialises in the design and execution of clinical trials of immune therapy for malignant disease. He works as part of a multidisciplinary framework in Birmingham including the CR-UK Clinical Trials Unit (CRCTU) and the Cancer Immunology and Immunotherapy Centre.He also works with international partners. He has a particular scientific interest in the immunology of cancers carrying ...

Graham is a Senior Lecturer/Senior Research Fellow with an interest in viral and cancer immunology and immunotherapy. Graham's work has led to a therapeutic cancer vaccine that has undergone testing in several clinical trials. 

Professor Daniel Tennant is a Professor of Biochemistry in the Institute of Metabolism and Systems Research (IMSR), situated on the second floor of the Institute of Biomedical Research. He uses stable isotope tracers to investigate changes in the use of nutrients in conditions where oxygen is limiting (hypoxia), or in the presence of genetic mutations that induce a hypoxia-like response. Dan ...

Kai Toellner is Professor of Adaptive Immunology at the Institute of Immunology and Immunotherapy and the Cancer and Immunology and Immunotherapy Centre Birmingham.

He studies how lymphocytes differentiate in response to pathogens or vaccines and how this leads to the generation of protective antibodies and long term immune memory. He has published over 70 research papers in international ...

Ben Willcox is based in the Institute of Immunology and Immunotherapy as Professor of Molecular Immunology and was the Cancer Research UK Birmingham Centre Scientific Director between 2017-2022.

Ben leads an active research group in the field of cancer immunology and immunotherapy, with a focus on understanding immune receptor recognition. His recent work focuses on novel tumour ...

David Withers is a Wellcome Trust funded Senior Research Fellow

Research in the Withers Lab is focused on understanding how memory CD4 T cell responses are generated and maintained, in particular the key cellular interactions that provide critical signals in this process. We are currently testing the role of RORgt-expressing group 3 Innate Lymphoid Cells versus other immune cell populations as ...